Alliance for Children’s Therapeutics Includes IBD, MS and Asthma in Their Studies

Alliance for Children’s Therapeutics Includes IBD, MS and Asthma in Their Studies
The Alliance for Children’s Therapeutics (ACT) was established last June by the Seattle Children’s Research Institute and biotechnology company Kineta with the purpose of being the first-of-its-kind pediatric research and funding partnership, and will now enlarge its reach of studies to inflammatory bowel disease (IBD), multiple sclerosis (MS) and asthma, as recently announced at the Partnering for Cures

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *